Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:THIS PRODUCT IS A PURIFIED ANTIBODY
PREPARATION USED FOR HUMAN INJECTION TO INDUCE TEMPORARY IMMUNITY
TO HEPATITIS B. THE PRODUCT IS DERIVED FROM HUMAN PLASMA WHICH HAS
TESTED POSITIVE FOR ANTIBODIES TO HEPATITIS B. PRODUCT IS PRODUCED
BY ISOLATION OF THE ANTIBODIES USING ETHANOL FRACTIONATION. (SEE
SUPP)
Explanation of Carcinogenicity:NONE
Effects of Overexposure:THIS PRODUCT IS A PURIFIED ANTIBODY PREPARATION
USED FOR HUMAN INJECTION TO INDUCE TEMPORARY IMMUNITY TO HEPATITIS
B. PRODUCT IS DERIVED FROM HUMAN PLASMA WHICH HAS TESTED POSITIVE
FOR ANTIBODIES TO H EPATITIS B. PRODUCT IS PRODUCED BY ISOLATION OF
THE ANTIBODIES USING ETHANOL FRACTIONATION. (SEE SUPP)
======================= First Aid Measures =======================
First Aid:SKIN: WASH AREA W/SOAP & WATER. OBTAIN MEDICAL ATTENTION IN
ALL CASES.
===================== Fire Fighting Measures =====================
Unusual Fire/Explosion Hazard:PRODUCT IS NEITHER FLAMMABLE NOR
EXPLOSIVE.
Spill Release Procedures:COLLECT/ABSORB ONTO INERT MATERIAL. PLACE IN
SUITABLE CONTAINER FOR PROMPT DISPOSAL. AREA SHOULD BE CLEANED
W/DILUTE (1 IN10) HOUSEHOLD BLEACH 0.5% SODIUM HYPOCHLORITE).
====================== Handling and Storage ======================
Handling and Storage Precautions:OPERATORS MAY WISH TO USE SAFETY
PIPETTE DEVICES, VIRAL DISINFECTING SOA FOR CLEANING. REASONABLE
PRECAUTIONS SHOULD BE TAKEN TO MINIMIZE CONTACT.
Other Precautions:AVOID CONTACT W/OPEN SKIN. THE HUMAN PLASMA HAS BEEN
TESTED & FOUND POSITIVE FOR ANTIBODIES TO HEPATITIS B. ETHANOL
FRACTIONATION TREATMENT IS KNOWN TO INACTIVATE HEPATITIS B VIRUS.
EMERGING VIRUSES M AY NOT BE INACTIVATED BY THIS TREATMENT.
Respiratory Protection:NONE
Ventilation:NONE
Protective Gloves:LATEX, VINYL
Eye Protection:NONE
Other Protective Equipment:DISPOSABLE
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
HEALTH HAZARDS CONT'D: THIS PROCESS IS DOCUMENTED TO PROVIDE VIRAL
INACTIVATION. THE ANTIBODY IS SUSPENDED IN AN AQUEOUS SOLUTION
WHICH CONTAINS A STABILIZER (GLYCINE) & A PRESERVATIVE
(THIMEROSAL).
Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS. DISPOSE IN AN APPROVED WASTE DISPOSAL FACILITY.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.